194 related articles for article (PubMed ID: 23912257)
1. Role of IL-8 induced angiogenesis in uveal melanoma.
Lattanzio L; Tonissi F; Torta I; Gianello L; Russi E; Milano G; Merlano M; Lo Nigro C
Invest New Drugs; 2013 Oct; 31(5):1107-14. PubMed ID: 23912257
[TBL] [Abstract][Full Text] [Related]
2. Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study.
Sudaka A; Susini A; Lo Nigro C; Fischel JL; Toussan N; Formento P; Tonissi F; Lattanzio L; Russi E; Etienne-Grimaldi MC; Merlano M; Milano G
Invest New Drugs; 2013 Feb; 31(1):59-65. PubMed ID: 22714791
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Yang H; Jager MJ; Grossniklaus HE
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2835-42. PubMed ID: 20089875
[TBL] [Abstract][Full Text] [Related]
4. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
5. Expression of angiogenic and immunosuppressive factors by uveal melanoma cell lines.
Ijland SA; Jager MJ; Heijdra BM; Westphal JR; Peek R
Melanoma Res; 1999 Oct; 9(5):445-50. PubMed ID: 10596910
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.
Sharma RK; Balaiya S; Chalam KV
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6906; author reply 6906-7. PubMed ID: 21123801
[No Abstract] [Full Text] [Related]
7. [Uveal Melanoma Cell Under Oxidative Stress - Influence of VEGF and VEGF-Inhibitors].
Dithmer M; Kirsch AM; Gräfenstein L; Wang F; Schmidt H; Coupland SE; Fuchs S; Roider J; Klettner AK
Klin Monbl Augenheilkd; 2019 Mar; 236(3):295-307. PubMed ID: 28376556
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines.
Dithmer M; Kirsch AM; Richert E; Fuchs S; Wang F; Schmidt H; Coupland SE; Roider J; Klettner A
Mar Drugs; 2017 Jun; 15(7):. PubMed ID: 28640204
[TBL] [Abstract][Full Text] [Related]
9. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.
Gammons MV; Lucas R; Dean R; Coupland SE; Oltean S; Bates DO
Br J Cancer; 2014 Jul; 111(3):477-85. PubMed ID: 25010863
[TBL] [Abstract][Full Text] [Related]
10. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
11. The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.
Li J; Cui Y; Wang Q; Guo D; Pan X; Wang X; Bi H; Chen W; Liu Z; Zhao S
Mol Vis; 2014; 20():649-60. PubMed ID: 24868139
[TBL] [Abstract][Full Text] [Related]
12. The dominant role of IL-8 as an angiogenic driver in a three-dimensional physiological tumor construct for drug testing.
Tan PH; Chia SS; Toh SL; Goh JC; Nathan SS
Tissue Eng Part A; 2014 Jun; 20(11-12):1758-66. PubMed ID: 24372172
[TBL] [Abstract][Full Text] [Related]
13. Autocrine impact of VEGF-A on uveal melanoma cells.
Koch KR; Refaian N; Hos D; Schlereth SL; Bosch JJ; Cursiefen C; Heindl LM
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2697-704. PubMed ID: 24677103
[TBL] [Abstract][Full Text] [Related]
14. Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
Boyd SR; Tan DS; de Souza L; Neale MH; Myatt NE; Alexander RA; Robb M; Hungerford JL; Cree IA
Br J Ophthalmol; 2002 Apr; 86(4):440-7. PubMed ID: 11914215
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic therapy in uveal melanoma.
El Filali M; Van der Velden PA; Luyten GPM; Jager MJ
Dev Ophthalmol; 2012; 49():117-136. PubMed ID: 22042017
[TBL] [Abstract][Full Text] [Related]
16. The effect of paclitaxel and nab-paclitaxel in combination with anti-angiogenic therapy in breast cancer cell lines.
Tonissi F; Lattanzio L; Merlano MC; Infante L; Lo Nigro C; Garrone O
Invest New Drugs; 2015 Aug; 33(4):801-9. PubMed ID: 25947567
[TBL] [Abstract][Full Text] [Related]
17. Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.
El Filali M; Homminga I; Maat W; van der Velden PA; Jager MJ
Mol Vis; 2008 Sep; 14():1752-9. PubMed ID: 18836566
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nicotinamide as an anti-inflammatory and anti-angiogenic agent in uveal melanoma cell lines.
Esposito E; Aldrees S; Mastromonaco C; Zoroquiain P; Vila N; Logan PT; Hari S; Burnier MN
Arq Bras Oftalmol; 2017; 80(2):74-77. PubMed ID: 28591277
[TBL] [Abstract][Full Text] [Related]
19. A novel 2-aminobenzimidazole-based compound Jzu 17 exhibits anti-angiogenesis effects by targeting VEGFR-2 signalling.
Lien JC; Chung CL; Huang TF; Chang TC; Chen KC; Gao GY; Hsu MJ; Huang SW
Br J Pharmacol; 2019 Oct; 176(20):4034-4049. PubMed ID: 31368127
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines.
Logan P; Burnier J; Burnier MN
Ecancermedicalscience; 2013; 7():336. PubMed ID: 23914254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
